Baltagianni Marianthi, Leivaditis Vasileios, Baltayiannis Nikolaos, Stanc Gabriela, Souka Efstathia, Batika Pella, Beltsios Eleftherios, Mulita Francesk, Papatriantafyllou Athanasios, Koletsis Efstratios N
Department of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, GRC.
Department of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, DEU.
Cureus. 2024 Sep 25;16(9):e70207. doi: 10.7759/cureus.70207. eCollection 2024 Sep.
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor classified as an intermediate malignancy that rarely metastasizes. The most common site for IMTs is the lung, though they can develop in various other anatomical locations. Pulmonary IMTs are more common in children and adolescents and are infrequently diagnosed in adults. This case report describes a 49-year-old woman with a history of breast cancer previously treated with subtotal mastectomy and chemotherapy who developed an IMT in the lung. This case emphasizes the rarity of the disease and the associated clinical challenges when managing such cases.
炎性肌纤维母细胞瘤（IMT）是一种罕见的间叶性肿瘤，归类为中间型恶性肿瘤，很少发生转移。IMT最常见的部位是肺，不过也可发生于其他各种解剖位置。肺部IMT在儿童和青少年中更为常见，在成人中很少被诊断出来。本病例报告描述了一名49岁女性，她有乳腺癌病史，之前接受过乳房次全切除术和化疗，后来肺部发生了IMT。该病例强调了这种疾病的罕见性以及处理此类病例时相关的临床挑战。
